An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
The 5th ProCAncer-I Consortium Meeting took place on the 07 – 08 November 2022, at ILO Campus, in Turin. The meeting was hybrid and more than 65 people attended the meeting. This was the first physical meeting where almost all partners were present, and we were glad to get to know each other. During the project, the progress and various issues for the implementation of the project were discussed
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces
The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...
ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...
Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...